PharmaShots | Incisive News in 3 Shots

Subscribe Now

Metastatic Urothelial Carcinoma

Merck KGaA and Pfizer Report EMA's Validation for Bavencio (avelumab) as a 1L Treatment for Locally Advanced or Metastatic Urothelial Carcinoma

Merck KGaA and Pfizer Report EMA's Validation for Bavencio (avelumab) as a 1L Treatment for Locally Advanced or Metastatic Urothel...

June 22, 2020

EMD Serono and Pfizer's Bavencio (avelumab) Receive the US FDA's Breakthrough Therapy Designation as 1L Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma

EMD Serono and Pfizer's Bavencio (avelumab) Receive the US FDA's Breakthrough Therapy Designation as 1L Maintenance Treatment of L...

April 9, 2020

Merck KGaA and Pfizer Report Results of Bavencio (avelumab) in P-III JAVELIN Bladder 100 Study for Patients with Locally Advanced or Metastatic Urothelial Carcinoma

Merck KGaA and Pfizer Report Results of Bavencio (avelumab) in P-III JAVELIN Bladder 100 Study for Patients with Locally Advanced...

January 7, 2020

Eisai Reports Results of Lenvima (Lenvatinib) + Keytruda (pembrolizumab) to Treat Metastatic NSCLC Metastatic Melanoma and Metastatic Urothelial Carcinoma

Eisai Reports Results of Lenvima (Lenvatinib) + Keytruda (pembrolizumab) to Treat Metastatic NSCLC Metastatic Melanoma and Metasta...

November 12, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us